Donor KIR2DS1 reduces the risk of transplant related mortality in HLA-C2 positive young recipients with hematological malignancies treated by myeloablative conditioning.

Attila TordaiAndras BorsKatalin Piroska KissKatalin BalassaHajnalka AndrikovicsArpad BataiAniko SzilvasiKatalin RajczyDora InotaiEva TorbagyiLilla LengyelAniko BartaPeter RemenyiTamas Masszi

Published in: PloS one (2019)

The combination of rC2+d2DS1 may be a favorable genetic constellation in allo-HSCT with MAC potentially reducing transplant related mortality.

Keyphrases

cardiovascular events
risk factors
stem cell transplantation
genome wide
cardiovascular disease
coronary artery disease
acute myeloid leukemia
allogeneic hematopoietic stem cell transplantation
acute lymphoblastic leukemia
copy number
middle aged
kidney transplantation